News

Find News

Filter articles

Applied Filters

Showing 1 to 10 of 2056 results

AbbVie says bar for ‘sham litigation’ is too low

US03-06-2021Rory O'Neill

AbbVie has again urged the US Supreme Court to save it from claims of filing sham litigation to block competition for testosterone treatment AndroGel.

UC Berkeley auctions Nobel Prize invention materials as NFTs

US01-06-2021Alex Baldwin

A non-fungible token for a Nobel Prize-winning cancer immunotherapy invention has been minted ahead of an auction tomorrow arranged by the University of California, Berkeley.

Philips settles ultrasound copyright claims

US27-05-2021Rory O'Neill

Philips has settled trade secrets and copyright claims against a medical imaging company, having already survived accusations of breaching antitrust law.

AbbVie, Taro settle over rosacea drug patents

US27-05-2021Rory O'Neill

AbbVie and its exclusive licensee have settled a patent lawsuit against Taro Pharmaceutical over a generic rosacea drug.

Takeda, Bayer settle $173m Adynovate suit

20-05-2021

Takeda subsidiary Baxalta has agreed to drop its fightback against a $173 million award in favour of Bayer after an appeals court upheld a patent infringement win for the German conglomerate.

Novartis withdraws bid to block US Regeneron imports

US04-05-2021Muireann Bolger

Pharmaceutical company Novartis has abandoned its attempt to halt US imports of Regeneron’s Eylea pre-filled syringes amid concerns that such a ban could hinder public access to essential treatments.

GSK claims Amgen v Sanofi decision “threatens” innovation

US29-04-2021Alex Baldwin

GlaxoSmithKline has submitted an amicus brief to the Court of Appeals for the Federal Circuit claiming that the ruling on Amgen v Sanofi could “threaten incentives to invest in future discoveries.”

Dr Reddy’s hits Amarin with antitrust suit over Vascepa

US29-04-2021Muireann Bolger

Amarin delayed the market entry of generic versions of the cardiovascular drug Vascepa by using supply agreements to halt competitors from accessing the drug’s active pharmaceutical ingredient, according to a new antitrust lawsuit.

Nicox verifies patent extension eligibility at USPTO

US22-04-2021Muireann Bolger

In a boon for eye care specialist Nicox, the United States Patent and Trademark Office has confirmed that one of its three patents covering a glaucoma treatment could be extended by up to five years.

L’Oreal wins infringement suit over ‘indefinite’ patents

US22-04-2021Muireann Bolger

L’Oreal has secured a victory after a US federal court ruled that the French cosmetics brand did not infringe patents owned by the University of Massachusetts because they were invalid.

Showing 1 to 10 of 2056 results

LSIPR